InMed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.About INM
InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. It operates through the InMed Pharma and BayMedica Commercial segments.
CEOEric A. Adams
CEOEric A. Adams
Employees13
Employees13
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded1981
Founded1981
Employees13
Employees13
INM Key Statistics
Market cap3.59M
Market cap3.59M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume179.36K
Average volume179.36K
High today$1.32
High today$1.32
Low today$1.20
Low today$1.20
Open price$1.32
Open price$1.32
Volume61.31K
Volume61.31K
52 Week high$8.27
52 Week high$8.27
52 Week low$1.13
52 Week low$1.13
Stock Snapshot
As of today, InMed Pharmaceuticals(INM) shares are valued at $1.28. The company's market cap stands at 3.59M, with a P/E ratio of -0.17.
As of 2025-12-16, InMed Pharmaceuticals(INM) stock has fluctuated between $1.20 and $1.32. The current price stands at $1.28, placing the stock +6.7% above today's low and -3.0% off the high.
InMed Pharmaceuticals(INM) shares are trading with a volume of 61.31K, against a daily average of 179.36K.
During the past year, InMed Pharmaceuticals(INM) stock moved between $1.13 at its lowest and $8.27 at its peak.
During the past year, InMed Pharmaceuticals(INM) stock moved between $1.13 at its lowest and $8.27 at its peak.
People also own
Based on the portfolios of people who own INM. This list is generated using Robinhood data, and it’s not a recommendation.